Projects per year
Abstract
Objective: To investigate causal associations between blood-based inflammatory markers and female infertility using Mendelian randomization (MR). Design: Mendelian randomization using genome-wide association study data. Setting: Publicly available genome-wide association study data. Patient(s): Large female-only cohorts of European ancestry. Intervention(s): Blood-based inflammatory markers (C-reactive protein, interleukins, monocyte chemoattractant protein-1, tumor necrosis factor-α, interferon-γ). Main Outcomes Measure(s): Anovulatory infertility (1,054 cases and 117,098 controls); female infertility of other/unspecified origin (5,667 cases and 117,098 controls); and medical treatment for female infertility (2,706 cases and 120,873 controls). Total causal effects were assessed using univariable two-sample methods including inverse variance weighted (IVW) as the primary analysis, as well as other secondary analyses (MR-Egger, weighted median, etc.), with relevant quality assessments. Result(s): Interleukin-8 demonstrated a positive association with anovulatory infertility via IVW (odds ratio, 95% confidence interval; 1.51, 1.04–2.21) and weighted median (1.64, 1.05–2.57) methods. Monocyte chemoattractant protein-1 was associated with anovulatory infertility via MR-Egger (2.06, 1.13–3.77). Inverse associations were found for interleukins-12 and -18 via IVW, with higher interleukin-12 being associated with lower medical treatment for female infertility (0.75, 0.59–0.94), whereas higher interleukin-18 was associated with lower female infertility of other/unspecified origin (0.90, 0.83–0.97). Conclusion(s): This is the first study to examine causal relationships between inflammation and female infertility using MR. Monocyte chemoattractant protein-1 and interleukin-8 are implicated in anovulatory infertility; however, only the relationship with interleukin-8 was evident in the primary analysis. Interleukins-12 and -18 demonstrated inverse associations with infertility outcomes. Further research is needed to uncover the mechanistic functions of these markers to confirm causality and examine their therapeutic potential for female infertility.
Original language | English |
---|---|
Pages (from-to) | 85-98 |
Number of pages | 14 |
Journal | F&S Science |
Volume | 6 |
Issue number | 1 |
DOIs | |
Publication status | Published - Feb 2025 |
Keywords
- Anovulation
- gene association
- infertility
- inflammation
- Mendelian randomization
Projects
- 3 Active
-
Implementation research: Delivering impact at the interface between reproductive and metabolic women’s health
1/01/22 → 31/12/26
Project: Research
-
Centre for Research Excellence - Women’s Health in Reproductive life
Teede, H. (Primary Chief Investigator (PCI)), Norman, R. J. (Chief Investigator (CI)), Mishra, G. D. (Chief Investigator (CI)), Boyle, J. (Chief Investigator (CI)), Hart, R. J. (Chief Investigator (CI)), Mol, B. (Chief Investigator (CI)), Moran, L. (Chief Investigator (CI)), Hickey, M. (Chief Investigator (CI)), Laven, J. S. E. (Chief Investigator (CI)) & Rodgers, R. J. (Chief Investigator (CI))
1/11/19 → 31/10/25
Project: Research
-
Plasma Lipidomic Signatures for Risk Prediction and Prevention of Gestational Diabetes
1/01/19 → 31/12/25
Project: Research